Karyopharm Therapeutics Current Assets

Karyopharm Therapeutics (KPTI) currently reports a current assets of $110M as of June 2026. That compares with $98M in the prior-year period — up 8.7% year over year. Use the charts on this page to explore Karyopharm Therapeutics's current assets history and peer comparisons.

Karyopharm Therapeutics's current assets increased from $98M to $110M — a 8.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Karyopharm Therapeutics reported $110M in current assets as of June 2026. That compares with $98M in the prior-year period — up 8.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Karyopharm Therapeutics, and consider following KPTI for alerts when major investors trade the stock.

Karyopharm Therapeutics is classified in the Healthcare sector. On current assets, it currently shows $110M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KPTI with unrelated industries.